Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is highly rated in 20 conditions, according to our data. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Dr. Lee is a specialist in Interventional Pulmonary and serves as the Wang Interventional Pulmonary Fellowship Director. His areas of clinical expertise include interventional pulmonology, pleural disease, minimal invasive diagnostics and lung cancer at Johns Hopkins. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management and difficulty airways. In addition, he specializes in the diagnosis and management of pleural diseases and symptom relief with minimally invasive procedures. He is a fellow of the American College of Chest Physicians and the Johns Hopkins Master of Education for Health Professionals. Dr. Lee is highly rated in 14 conditions, according to our data. His top areas of expertise are Pleural Effusion, Lung Nodules, Lymphofollicular Hyperplasia, Endoscopy, and Advanced Bronchoscopy.

Dr. Danoff is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and Co-Director of the Hopkins Interstitial Lung Disease Clinic. She is a specialist in diseases causing fibrosis or scarring in the lung, particularly those associated with autoimmune diseases including myositis. Dr. Danoff is highly rated in 12 conditions, according to our data. Her top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Endoscopy, and Lung Transplant.

Dr. Yarmus is a Professor of Medicine and Oncology and the director of Interventional Pulmonology at the Johns Hopkins University School of Medicine as well as the Vice Chair of Medicine for Strategy and Finance. He is an expert in the minimally invasive diagnosis and treatment of lung cancer and he leads the Interventional Pulmonary research program at Johns Hopkins with research investigating innovative minimally invasive device development and early-stage bronchoscopic treatments. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management, pleural diseases and symptom relief with minimally invasive procedures such as indwelling pleural catheters and pleurodesis. Dr. Yarmus is a member of the Fleischner Society and a fellow of the American College of Chest Physicians and the American Thoracic Society. Dr. Yarmus is highly rated in 10 conditions, according to our data. His top areas of expertise are Pleural Effusion, Lung Nodules, Lymphofollicular Hyperplasia, Endoscopy, and Advanced Bronchoscopy.

Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins. Dr. Mathai is highly rated in 9 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant.

Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is highly rated in 9 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Sarcoidosis, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Lung Transplant.

Dr. Liu is a pulmonary physician with additional expertise in allergy and immunology. He is an expert in the diagnosis and treatment of patients with severe asthma with a focus on developing new treatments for severe disease that has failed to respond to standard therapies. Dr. Liu is highly rated in 9 conditions, according to our data. His top areas of expertise are Eosinophilic Asthma, Simple Pulmonary Eosinophilia, Eosinophilic Pneumonia, Chronic Eosinophilic Pneumonia, and Gastrostomy.

Paul M. Hassoun, M.D., is professor of medicine at the Johns Hopkins University School of Medicine and the director of the pulmonary hypertension program at Johns Hopkins Hospital. He received his medical degree from the Faculté de Médecine Lariboisière-Saint Louis at the University of Paris, France, completed an internship and residency at Brigham and Women’s Hospital and a fellowship in Pulmonary and Critical Care Medicine at Massachusetts General Hospital, both at Harvard Medical School. He was on faculty in the pulmonary division at New England Medical Center/Tufts University School of Medicine (Tufts-NEMC) in Boston, MA, until 2002 when he joined the division of pulmonary and critical care medicine at Johns Hopkins University. Dr. Hassoun has served or currently serves on numerous American Thoracic Society (ATS) assemblies and committees, including the Pulmonary Circulation Long Range Planning Committee, the Pulmonary Circulation Program Committee (for which he served as chair for 2008-2009), the ATS Scientific Advisory Council, Pulmonary Circulation Leadership Committee, and the American College of Chest Physicians Vascular Steering Committee. He served as the ATS Pulmonary Circulation chair (2011-2012) and on the ATS Publications Policy Committee. He was recently elected president of the Pulmonary Vascular Research Institute (PVRI; 2018-2019). Dr. Hassoun has held numerous editorial activities including serving on the editorial board of the American Journal of Respiratory and Critical Medicine (2010 to present), CHEST (2006-2015) and the European Respiratory Review (2008-2015). He currently serves as associate editor of the European Respiratory Journal (2013-present) and has served as associate editor for the Journal of Clinical Investigation (2017-2022). Dr. Hassoun is highly rated in 7 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Lung Transplant.

Dr. Hansel is a pulmonary and critical care medicine physician. She is an expert in the diagnosis and treatment of obstructive airway diseases, including asthma and chronic obstructive pulmonary disease (COPD), and care of patients in the Medical ICU. Dr. Hansel is highly rated in 5 conditions, according to our data. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Asthma, Bronchitis, and Endoscopy.

Dr. Jun is a pulmonary, critical care, and sleep medicine physician. He is an expert in the diagnosis and treatment of sleep-disordered breathing, and in the care of critically ill patients in the Medical ICU. He is a member of the Sleep Fellowship Program Evaluation and Clinical Competency Committee and provides teaching to medical students and residents at Johns Hopkins. Dr. Jun is highly rated in 4 conditions, according to our data. His top areas of expertise are Cerebral Hypoxia, Obstructive Sleep Apnea, Central Sleep Apnea, and Obesity Hypoventilation Syndrome (OHS).

Dr. Lechtzin is a pulmonary and critical care medicine physician. He directs the Adult CF program and the neuromuscular pulmonary clinic at Johns Hopkins and is an expert in the treatment of cystic fibrosis, pulmonary complications of neuromuscular disease and the care of critically ill patients in the Medical ICU. He is a member of the Longcope Firm Faculty and provides teaching to medical students and residents at Johns Hopkins. Dr. Lechtzin is highly rated in 3 conditions, according to our data. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Lung Transplant, and Endoscopy.

Dr. Putcha is a pulmonary and critical care physician. She is an expert in the diagnosis and treatment of lung disease (specifically obstructive lung diseases such as COPD and asthma), and in the care of critically ill patients in the Medical ICU. She is a member of the Lung Research Conference Planning Committee and provides teaching to medical students and residents at Johns Hopkins. Dr. Putcha is highly rated in 3 conditions, according to our data. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Cerebral Hypoxia, and Asthma.

Dr. Natalie West is a pulmonary specialist in the Greater Baltimore area who specializes in the diagnosis and treatment of cystic fibrosis. Her focus also includes the treatment of interstitial lung disease, lung transplantation, COPD, asthma, and pulmonary hypertension. She also manages patients in the medical intensive care unit with acute respiratory failure caused by asthma, pneumonia, COPD, and the acute respiratory distress syndrome, as well as other conditions such as gastrointestinal bleeding, pulmonary embolism, diabetic ketoacidosis, and shock from sepsis, hypovolemia, and heart disease. Dr. West also serves as the associate program director of the Johns Hopkins Pulmonary and Critical Care Fellowship Program and plays an active role in recruitment of new fellows and mentoring fellows in the division. Dr. West is highly rated in 3 conditions, according to our data. Her top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Pseudomonas Stutzeri Infections, and Lung Transplant.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is highly rated in 45 conditions, according to our data. His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Dr. Howard Steiner is an instructor of medicine at the Johns Hopkins School of Medicine. He has been practicing pulmonary and sleep consultative medicine since 1989. In his role as a diagnostician, he guides the evaluation and management of respiratory problems including infectious, malignant, allergic, autoimmune, and sleep-related disorders. He has been part-time faculty in the Johns Hopkins Pulmonary Division since 1991, is a Fellow in the American College of Chest Physicians, and mentors medical students, residents, and pulmonary fellows training at the Johns Hopkins Hospital. Contact for Research Inquiries 10755 Falls Road Pavilion I, Suite 200 Lutherville, MD 21093 Phone: (410) 583-7124 Selected Publications Lwebuga-Mukasa JS, Steiner H. Monoclonal antibody to rat lung Maclura Pomifera agglutinin (MPA) lectin binding glycoprotein localizes apically on rat and human type II pneumocytes and Clara cells. J Cell Biol 107:71a, 1989. Roberts PJ, McBean GJ, Steiner H, Kohler C, Schwarcz R. Lesioning Effects of Ibotenate in the immature rat brain and protection by 2-amino-7 phosphonoheptanoic acid. Soc Neurosci Abst 9:261, 1983. Steiner H, Ingbar DI. Mechanisms of lung injury and repair. In: Matthay RA, Matthay MA, Wiedemann HP eds. Annual Review of Pulmonary and Critical Care Medicine. Hanley & Belfus (Philadelphia, 1989), pp 205-223. Steiner H, Lwebuga-Mukasa JS. A549 cells display distinct functional and morphologic properties depending on their culture substratum. J Cell Biol 107:71a, 1989. Steiner H, Lwebuga-Mukasa JS. A549 cells produce a factor which is Mitogenic for human lung fibroblasts. Amer Rev Resp Dis 139:A492 1989. Steiner H, McBean GJ, Kohler C, Roberts PJ, Schwarcz R. Ibotenate Induced neuronal degeneration in immature rat brain. Brain Research 307:117-124, 1984. Dr. Steiner is highly rated in 20 conditions, according to our data. His top areas of expertise are Bronchiectasis, Obstructive Sleep Apnea, Lung Metastases, and Interstitial Lung Disease.

Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Brodie is highly rated in 8 conditions, according to our data. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Respiratory Acidosis, COVID-19, Lung Transplant, and Embolectomy.

Christine Argento is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Argento is highly rated in 8 conditions, according to our data. Her top areas of expertise are Pleural Effusion, Lymphofollicular Hyperplasia, Lung Nodules, Endoscopy, and Gastrostomy.

Dr. Gregory Diette is a professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in the Department of Epidemiology in the Johns Hopkins Bloomberg School of Public Health. He has over 20 years of experience diagnosing and managing complex and challenging pulmonary conditions. He is expert in the diagnosis and treatment of patients with common conditions such as asthma and COPD, as well as uncommon conditions such as allergic bronchopulmonary aspergillosis (ABPA), bronchiolitis obliterans, hypersensitivity pneumonitis and others. His practice includes evaluation of patients with unexplained shortness of breath and cough as well as patients with a variety of environmental lung conditions. In addition to his outpatient practice, Dr. Diette provides inpatient care on the pulmonary, critical care and internal medicine services. Dr. Diette earned his M.D. from the Temple University School of Medicine. He completed his residency at the Hospital of the University of Pennsylvania and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. He received his M.H.S. from the Johns Hopkins Bloomberg School of Public Health. His research interests include environmental impacts on lung disease, epidemiology of airway disease and chronic obstructive pulmonary disease. Dr. Diette is highly rated in 7 conditions, according to our data. His top areas of expertise are Asthma, Allergic Bronchopulmonary Aspergillosis, Pulmonary Aspergilloma, and Aspergillosis.

Dr. Checkley specializes in intensive care medicine. He is an expert in the diagnosis and management of acute respiratory failure and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions commonly seen in the medical intensive care unit, including septic shock, acute gastrointestinal bleeding, acute liver failure, among other critical conditions. Dr. Checkley earned his M.D. from Northwestern University and received his Ph.D. from Johns Hopkins University. He completed his internal medicine residency training at Emory University and fellowship training in pulmonary and critical care medicine at Johns Hopkins School of Medicine. His research interests include International lung health, epidemiology, mechanical ventilation and acute lung injury. Dr. Checkley has been recognized by the National Institute of Health with the 2007 Post-doctoral National Research Service Award and the 2009 Pathway to Independence Career Award. Dr. Checkley is highly rated in 7 conditions, according to our data. His top areas of expertise are Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Cerebral Hypoxia.

Dr. Karthik Suresh is a pulmonary and critical care physician. His clinical interests include acute lung injury and critical care medicine. He also specializes in the diagnosis and management of immune-related lung injury, especially in the context of autoimmune conditions and chemotherapy/immunotherapy for cancer. Dr. Suresh is a member of the Hopkins immune-related adverse events (irAE) tox team. He also takes care of critically ill patients in the medical and oncology ICUs. He’s a firm faculty member for the Janeway Firm of the Osler Housestaff Medical Service and provides teaching to medical students, housestaff and fellows. Dr. Suresh is highly rated in 6 conditions, according to our data. His top areas of expertise are Pneumonia, Interstitial Lung Disease, Acute Interstitial Pneumonia, and Pulmonary Hypertension.

Dr. Neptune is a pulmonary, critical care physician with expertise in genetic disorders of the matrix with pulmonary manifestations. She is also skilled in the management of patients with advanced obstructive lung disease, especially emphysema. Dr. Neptune has extensive expertise in the diagnosis and management of the pulmonary complications of Marfan Syndrome, Loeys-Dietz Syndrome, vascular Ehlers Danlos Syndrome and other matrix disorders and serves on the Professional Advisory Board of the Marfan Foundation. She is also an expert on tobacco dependence and is the Vice-Chair of the Tobacco Action Committee of the American Thoracic Society. Dr. Neptune earned her M.D. from Harvard Medical School. She completed her residency and performed a fellowship in pulmonary and critical care at the University of California, San Francisco. She also performed a fellowship in genetics at Johns Hopkins. Her research interests include therapeutic strategies in Marfan syndrome; mechanisms and prevention of progression of COPD; and hepatocyte growth factor signaling in airspace homeostasis. Dr. Neptune is committed to creating a diverse research community and clinical workforce. She is involved in multiple diversity initiatives at Johns Hopkins and the American Thoracic Society. She is also involved in increasing awareness of tobacco dependence and the needed regulatory policies. Dr. Neptune serves on the Compliance Compensation Subcommittee for the Department of Medicine. Dr. Neptune is highly rated in 5 conditions, according to our data. Her top areas of expertise are Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Acute Interstitial Pneumonia, Interstitial Lung Disease, and Emphysema.

Roy Brower is a Professor of Medicine at Johns Hopkins University and was Medical Director of the Medical Intensive Care Unit at Johns Hopkins Hospital for over 30 years. He obtained his M.D. degree and completed his residency and fellowship in Pulmonary and Critical Care Medicine at Johns Hopkins. Brower’s earlier research explored mechanisms of cardiopulmonary interactions and pulmonary circulation physiology. He subsequently focused research efforts in the clinical venue. Brower has led four multicenter clinical trials of lung-protective mechanical ventilation strategies in patients with the acute respiratory distress syndrome (ARDS). One of these trials demonstrated substantially improved clinical outcomes in ARDS patients who received mechanical ventilation with lower tidal volumes. Brower was a member of the NIH ARDS Network from its inception in 1994. He was the Chair of the Steering Committee of the NIH Prevention and Early Treatment of Acute Lung Injury (PETAL) Network from 2014 to 2023. Brower has been actively involved in the American Thoracic Society. He served on the Program Committee of the Pulmonary Circulation Assembly and chaired the ATS Critical Care Assembly Planning Committee for two years. He served as chair of the Critical Care Assembly from 2003-2005 and is the recipient of the Critical Care Lifetime Achievement Award. Brower chaired the ATS Publications Policy Committee from 2012 to 2016 and twice received the ATS Presidential Citation. Brower is an accomplished clinical educator. The Johns Hopkins Osler Medical Residency Program awarded him its annual award for outstanding teaching twice, in 1996 and in 2015. The Johns Hopkins Pulmonary and Critical Care Medicine Fellowship program awarded him its annual Fellows Teaching Award in 2009. As the former Medical Director of the Medical Intensive Care Unit at Johns Hopkins Hospital, Brower focused the energy of the critical care staff to develop rigorous, evidence-based protocols and practice guidelines. He promotes standardization of care with good protocols because they help to reduce medical errors, improve the clinical research environment, and serve as effective teaching tools. Dr. Brower is highly rated in 4 conditions, according to our data. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, Acute Interstitial Pneumonia, Lung Transplant, and Gastrostomy.

Dr. Rebecca Dezube is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are cystic fibrosis and critical care medicine. She sees patients in the adult cystic fibrosis (CF) clinic as well as in the medical intensive care unit (MICU). She received her A.B. from Harvard University and earned her M.D. from Vanderbilt University School of Medicine. She completed her residency in internal medicine at Johns Hopkins, where she also served as an Assistant Chief of Service. She also trained as a fellow in pulmonary and critical care medicine at Johns Hopkins and served as the Chief Fellow in Pulmonary and Critical Care Medicine. Dr. Dezube joined the Johns Hopkins faculty in 2017. Dr. Dezube is highly rated in 3 conditions, according to our data. Her top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), and Newborn Jaundice.

Dr. Pham is a physician who specializes in pulmonary, critical care, and sleep medicine. He provides care for critically ill patients in the Medical ICU. His clinical focus is in the diagnosis and management of sleep-disordered breathing. He provides teaching to medical students, residents, and fellows at Johns Hopkins. Lab Website Polotsky Research Lab - Lab Website Research Summary Dr. Pham’s research focus is on the mechanisms and impact of sleep disordered breathing, with a particular emphasis on the role of hypoxia. His research interests have led him to the highlands of Peru, where he collaborates extensively with the CRONICAS cohort investigators to characterize the impact of hypoxia on respiratory patterns, cardiovascular responses and metabolism. He is currently involved in developing low-cost readily deployable strategies to treat sleep disordered breathing at high altitude. He has also pursued his research interests by modeling the metabolic impact of ambient hypoxia in the sleep lab. As a member of the leadership of the Center for Interdisciplinary Sleep Research and Education (CISRE), he is committed to improving investigators’ access to sleep recording and data analysis. Dr. Van Pham is highly rated in 3 conditions, according to our data. His top areas of expertise are Obstructive Sleep Apnea, Cerebral Hypoxia, Central Sleep Apnea, and Obesity Hypoventilation Syndrome (OHS).

Dr. Chen practices Pulmonary and Critical Care Medicine. His primary area of interest is sarcoidosis, and he has extensive experience in the diagnosis and treatment of sarcoidosis in all of its forms, and the management of consequences of this systemic disease. The Sarcoidosis Clinic often serves to coordinate management of patients with multi-organ involvement with sarcoidosis, and to this end Dr. Chen actively maintains clinical and research collaborations with Cardiology, Cardiovascular Nuclear Medicine, Neurology, and Ophthalmology. Additionally, Dr. Chen participates as a Physician Champion in the Johns Hopkins Health System Epic project to improve the safety and quality of care of critically ill patients through optimization of the electronic medical record. His work involves developing systems-based approaches to complex management issues, including sepsis and severe alcohol withdrawal. Dr. Chen is highly rated in 3 conditions, according to our data. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lung Metastases, and Acute Interstitial Pneumonia.